Royal Bank Of Canada Ligand Pharmaceuticals Inc Transaction History

Royal Bank Of Canada

$479 Billion
Q4 2024

A detailed history of Royal Bank Of Canada transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 4,864 shares of LGND stock, worth $526,041. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,864

Previous 4,130 17.77%

Holding current value

$526,041

Previous $413,000 26.15%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$99.95 - $129.9 $73,363 - $95,346	734 Added 17.77%	4,864 $521,000
Q3 2024 Nov 14, 2024	BUY	$82.7 - $110.11 $48,875 - $65,075	591 Added 16.7%	4,130 $413,000
Q2 2024 Aug 14, 2024	BUY	$68.53 - $87.91 $85,936 - $110,239	1,254 Added 54.88%	3,539 $298,000
Q1 2024 Nov 05, 2024	SELL	$68.64 - $89.2 $86,074 - $111,856	-1,254 Reduced 35.43%	2,285 $167,000
Q1 2024 May 15, 2024	SELL	$68.64 - $89.2 $322,813 - $419,507	-4,703 Reduced 67.3%	2,285 $167,000
Q4 2023 Feb 14, 2024	BUY	$49.57 - $72.63 $84,814 - $124,269	1,711 Added 32.42%	6,988 $499,000
Q3 2023 Nov 14, 2023	BUY	$58.86 - $72.67 $17,716 - $21,873	301 Added 6.05%	5,277 $316,000
Q2 2023 Aug 14, 2023	BUY	$69.53 - $79.33 $140,102 - $159,849	2,015 Added 68.05%	4,976 $358,000
Q1 2023 May 15, 2023	SELL	$65.67 - $77.08 $131,996 - $154,930	-2,010 Reduced 40.43%	2,961 $217,000
Q4 2022 Feb 14, 2023	BUY	$61.72 - $96.74 $176,334 - $276,386	2,857 Added 135.15%	4,971 $332,000
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $2 - $25,061	233 Added 12.39%	2,114 $183,000
Q2 2022 Aug 15, 2022	SELL	$74.52 - $117.06 $62,298 - $97,862	-836 Reduced 30.77%	1,881 $168,000
Q1 2022 May 16, 2022	SELL	$94.99 - $151.56 $244,314 - $389,812	-2,572 Reduced 48.63%	2,717 $306,000
Q4 2021 Feb 14, 2022	BUY	$127.69 - $165.85 $146,077 - $189,732	1,144 Added 27.6%	5,289 $817,000
Q3 2021 Nov 15, 2021	SELL	$102.33 - $144.73 $1.84 Million - $2.61 Million	-18,001 Reduced 81.28%	4,145 $578,000
Q2 2021 Aug 16, 2021	BUY	$113.03 - $155.64 $2.5 Million - $3.45 Million	22,146 New	22,146 $2.91 Million

Others Institutions Holding LGND

# of Institutions

277

Shares Held

18.5M

Call Options Held

30.8K

Put Options Held

5.2K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.83B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Ligand Pharmaceuticals Inc Transaction History